Theraclion Announces FDA Authorization to Start US Trial for Immunotherapy and Echotherapy Combination on Breast … – Business Wire (press release)
|
Theraclion Announces FDA Authorization to Start US Trial for Immunotherapy and Echotherapy Combination on Breast …
Business Wire (press release) Immunotherapy stimulates the body's own immune system to fight tumor cells. HIFU, which has already demonstrated its efficacy in the treatment of malignant and benign tumors, could have a major impact on the efficacy of immunotherapy when delivered as … |
